Cameco (NYSE:CCJ – Get Free Report) (TSE:CCO) is scheduled to be releasing its earnings data before the market opens on Thursday, February 8th. Analysts expect Cameco to post earnings of $0.21 per share for the quarter.
Cameco Stock Performance
Shares of CCJ stock opened at $48.50 on Tuesday. Cameco has a 52 week low of $23.69 and a 52 week high of $51.33. The company has a debt-to-equity ratio of 0.08, a quick ratio of 3.31 and a current ratio of 3.85. The company’s 50 day moving average price is $45.56 and its two-hundred day moving average price is $40.77. The company has a market capitalization of $21.06 billion, a P/E ratio of 109.82 and a beta of 0.96.
Institutional Trading of Cameco
Hedge funds and other institutional investors have recently modified their holdings of the stock. Tyler Stone Wealth Management acquired a new stake in Cameco during the second quarter worth approximately $32,000. 1832 Asset Management L.P. boosted its stake in Cameco by 61.9% in the 1st quarter. 1832 Asset Management L.P. now owns 1,700 shares of the basic materials company’s stock valued at $49,000 after purchasing an additional 650 shares during the period. Castleview Partners LLC bought a new position in Cameco during the 2nd quarter worth $94,000. Northwestern Mutual Wealth Management Co. lifted its holdings in shares of Cameco by 50.9% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 4,447 shares of the basic materials company’s stock worth $101,000 after buying an additional 1,500 shares in the last quarter. Finally, SkyView Investment Advisors LLC acquired a new position in shares of Cameco in the first quarter valued at about $157,000. Institutional investors own 66.57% of the company’s stock.
Analysts Set New Price Targets
Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services.
- Five stocks we like better than Cameco
- What Is WallStreetBets and What Stocks Are They Targeting?
- Alphabet triggers a sell-the-news reaction: Time to buy the dip?
- Health Care Stocks Explained: Why You Might Want to Invest
- Is Humana’s pain HCA Healthcare’s gain?
- Consumer Discretionary Stocks Explained
- Skechers stocks trips on inventory bloat, but there’s an upside
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.